Beyond the Swell: Decoding the Enigma of Bilateral Hand Angioedema in Response to Sacubitril–valsartan Therapy
Angioedema is a rare yet potentially life-threatening side effect associated with renin–angiotensin–aldosterone inhibitors. With angiotensin receptor neprilysin inhibitor replacing angiotensin converting enzyme inhibitors as the preferred treatment for heart failure with reduced ejection fraction, i...
Saved in:
Main Authors: | Samantha Aster Pinto, Joel Quadros Piedade, Venkatesh Malali, Amar Prabhudesai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-10-01
|
Series: | Journal of Clinical and Preventive Cardiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jcpc.jcpc_25_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01) -
Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
by: Neeraj Hiremath, et al.
Published: (2024-04-01) -
Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open‐Label, Noninferiority Study (PARASOL Study)
by: Koichi Yamamoto, et al.
Published: (2025-01-01) -
Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema
by: Artur Gęsicki, et al.
Published: (2024-08-01) -
Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
by: Roda Plakogiannis, et al.
Published: (2025-02-01)